Molecular Basis of Recovering on Mechanical Circulatory Support

Heart Failure Clinics

Volumn 10, Issue 1 SUPPL., 2014, Pages

  Nsair, Ali ^a   Liem, David A ^a   Cadeiras, Martin ^a   Cheng, Richard K ^a   Allareddy, Mrudula ^a   Kwon, Murray ^a   Shemin, Richard ^a   Deng, Mario C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advanced heart failure; Mechanical circulatory support; Molecular mechanisms; Reverse remodeling

Indexed keywords

CLENBUTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; METALLOTHIONEIN; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; VINCULIN;

ANEURYSM SURGERY; ASSISTED CIRCULATION; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; ENERGY METABOLISM; FORWARD HEART FAILURE; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART PERFUSION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; META ANALYSIS; METABOLOMICS; MITOCHONDRIAL RESPIRATION; MITRAL VALVE REPLACEMENT; MOLECULAR BIOLOGY; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PROTEOMICS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ADVANCED HEART FAILURE; MECHANICAL CIRCULATORY SUPPORT; MOLECULAR MECHANISMS; REVERSE REMODELING;

DECISION MAKING; HEART; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; VENTRICULAR REMODELING;

EID: 84888033825     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.08.007     Document Type: Review

References (30)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
2. Deng M.C., Ardehali A., Shemin R., et al. Relative roles of heart transplantations and long term mechanical circulatory support in contemporary management of advanced heart failure-a critical appraisal ten years after REMATCH. Eur J Cardiothorac Surg 2011, 40:781-782.
3. Reinlib L., Abraham W., Working Group of the National, Heart, Lung, and Blood Institute Recovery from heart failure with circulatory assist: a working group of the National, Heart, Lung, and Blood Institute. JCard Fail 2003, 9:459-463.
4. Everett A.D., Tufro-McReddie A., Fisher A., et al. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994, 23:587-592.
5. Pieske B. Reverse remodeling in heart failure-fact or fiction?. Eur Heart J 2004, 6(Suppl D):D66.
6. Rose A.G., Park S.J. Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts. Cardiovasc Pathol 2005, 14:19-23.
7. Klotz S., Jan Danser A.H., Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008, 97:479-496.
8. Ambardekar A.V., Buttrick P.M. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail 2011, 4:224-233.
9. Drakos S.G., Kfoury A.G., Selzman C.H., et al. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol 2011, 26:245-255.
10. Birks E.J., Hall J.L., Barton P.J., et al. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 2005, 112(Suppl 9):I57-I64.
11. Plenz G., Baba H.A., Erren M., et al. Reversal of myocardial interleukin-6-mRNA expression following longterm left ventricular assist device support for myocarditis-associated low output syndrome. JHeart Lung Transplant 1999, 18:923-924. [letter].
12. Kucuker S.A., Stetson S.J., Becker K.A., et al. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. JHeart Lung Transplant 2004, 23(1):28-35.
13. Baba H.A., Schmid C., August C., et al. Reversal of metallothionein expression of the human myocardium after prolonged left ventricular mechanical support. JHeart Lung Transplant 2000, 19:668-674.
14. Mueller J., Wallukat G., Weng Y.G., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997, 96:542-549.
15. Reiss N., El-Banayosy A., Arusoglu L., et al. Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist. ASAIO J 2006, 52:211-214.
16. Slaughter M.S., Bostic R., Tong K., et al. Temporal changes in hospital costs for left ventricular assist device implantation. JCard Surg 2011, 26:535-541.
17. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001, 104:881-886.
18. Heerdt P.M., Schlame M., Jehle R., et al. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg 2002, 73:1216-1221.
19. Rodrigue-Way A., Burkhoff D., Geesaman B.J., et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. JHeart Lung Transplant 2005, 24:73-80.
20. Margulies K.B., Matiwala S., Cornejo C., et al. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 2005, 96:592-599.
21. Hall J.L., Birks E.J., Grindle S., et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007, 28:613-627.
22. Baba H.A., Stypmann J., Grabellus F., et al. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res 2003, 59:390-399.
23. Flesch M., Margulies K.B., Mochmann H.C., et al. Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 2001, 104:2273-2276.
24. Chien K.R. Genomic circuits and the integrative biology of cardiac diseases. Nature 2000, 407:227-232.
25. Lee S.H., Doliba N., Osbakken M., et al. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. JThorac Cardiovasc Surg 1998, 116:344-349.
26. Mital S., Loke K.E., Addonizio L.J., et al. Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. JAm Coll Cardiol 2000, 36:1897-1902.
27. Agnetti G., Kaludercic N., Kane L.A., et al. Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet 2010, 3:78-87.
28. Kassiotis C., Ballal K., Wellnitz K., et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation 2009, 120:S191-S197.
29. Wohlschlaeger J., Sixt S.U., Stoeppler T., et al. Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium. JHeart Lung Transplant 2010, 29:125-132.
30. Weiss J.N., Karma A., MacLellan W.R., et al. "Good enough solutions" and the genetics of complex diseases. Circ Res 2012, 111:493-504.